Jourden-KY (Stock Code: 4190), which operates in the biotechnology and medical care sector, announced its revenue for March 2026. The monthly revenue was 208,898 thousand NTD (approximately NT$209 million), representing a slight decrease of 0.5% compared to the same month last year.

FACT BOX

  • Source: PR Times
  • Category: News